During Covid-19 Pandemic, Biotech IPOs Already Surpass Record

So far this year, U.S.-listed biotech companies have raised roughly $9.4 billion in initial public offerings, already beating the $6.5 billion raised in all of 2018, the biggest year on record, according to Dealogic data going back to 1995. This year’s biotech issues have jumped an average of 34% on their first day of trading,…

So far this year, U.S.-listed biotech companies have raised roughly $9.4 billion in initial public offerings, already beating the $6.5 billion raised in all of 2018, the biggest year on record, according to Dealogic data going back to 1995.

This year’s biotech issues have jumped an average of 34% on their first day of trading, the biggest average first-day pop for the sector since the tech boom in 2000.

The…

Read More

Related articles

Marquee Brands Bids $50 Million for Destination Maternity

Bankrupt retailer Destination Maternity Corp. will shut down its remaining 235 retail stores under a deal that would see a licensing firm buy the company’s brand name and other assets for $50 million. A licensing platform backed by Neuberger Berman Group LLC has agreed to acquire the e-commerce business, brand name and intellectual property of…

Blackstone Says Any Real Estate Deal Is Possible

Need help? Contact us We’ve detected unusual activity from your computer network To continue, please click the box below to let us know you’re not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…